Evasion of host immunity by the M protein
M蛋白逃避宿主免疫
基本信息
- 批准号:10438582
- 负责人:
- 金额:$ 61.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcuteAmino Acid SequenceAmino AcidsAntibodiesAntigensAttenuatedAutoimmuneBacteriaBindingBinding ProteinsBloodBuffaloesCell WallCollaborationsComplement 3bComplement Factor HComplexConsensusCrystallizationDepositionDevelopmentDiseaseFibrinogenGoalsHandHumanImmuneImmune systemImmunityInfectionKnowledgeLeadLifeMicrobiologyMorbidity - disease rateNatureOpsoninPatternPhagocytesPrevention strategyPropertyProteinsPublic HealthPublishingReportingResearch PersonnelResistanceRoleSeaStreptococcus pyogenesSurfaceTestingTherapeuticVaccine DesignVaccinesVariantVirulenceVirulence FactorsWorkX-Ray Crystallographycomplement 4b-binding proteindesignmortalitymultiple myeloma M Proteinneutralizing antibodynovelnovel therapeuticspathogenic bacteriaprotein complexrecruitstreptococcal M proteinsuccessuptake
项目摘要
Group A Streptococcus (GAS, S. pyogenes) remains a major public health threat. This widespread Gram-
positive bacterial pathogen causes acute invasive diseases and gives rise to severe autoimmune sequelae,
and is responsible for morbidity and mortality on a global scale. An essential virulence factor of GAS, the
antigenically variable M protein, enables the bacterium to evade opsonophagocytic killing by the immune
system. The M protein confers this indispensable function of phagocyte resistance by recruiting specific soluble
human proteins to the GAS surface that block the deposition of the major opsonin C3b as well as antigen-
specific opsonic antibodies — namely, C4b-binding protein (C4BP), factor H (FH), and fibrinogen (Fg). In
some GAS strains, an M-like protein serves this function. More than 220 M types are known, and while most M
protein types bind C4BP, FH, or Fg, or a combination of these, no consensus binding motif is evident in M and
M-like proteins for any of these human proteins, except most recently for C4BP due to our breakthrough. This
is because the exposed portion of the M protein that recruits these anti-opsonic human proteins is
sequence variable. While inhibition of these interactions has been shown to render GAS sensitive to immune
killing, the lack of consensus binding motifs has hindered the therapeutic goal of targeting these
interactions. Our recent breakthrough, reported in Buffalo et al., offers a solution to this problem. In effect, we
found that hidden within the variable region of many M proteins is a three-dimensional (3D) pattern that
is conserved for binding C4BP. This 3D C4BP-binding pattern in the M protein is dispersed (or hidden)
within a sea of variable amino acids, which makes the 3D pattern nearly impossible to identify by primary
sequence alone. However with structural knowledge in hand as a guiding template, the 3D pattern becomes
easily recognizable within the primary sequence of many M types. We hypothesize that just as with C4BP,
hidden within the variable regions of M and M-like proteins are 3D patterns that are conserved for
binding FH and Fg. We propose to test this emerging theme of conservation hidden within variability by
unveiling potentially conserved FH- and Fg-binding 3D patterns in M and M-like proteins. We also propose to
complete our work on C4BP, as the 3D pattern we discovered and published in Buffalo et al. explains only
about a half of the set of M proteins implicated in C4BP binding. We propose to carry this out through X-ray
crystallography. We have an extensive record of success with crystallographic studies of the M protein, and
have obtained initial co-crystals of M proteins bound to C4BP, FH, and Fg. In each case, we will take
advantage of the highly detailed level of information provided by our structural studies to determine the precise
functional contributions of each of these interactions to virulence through our long-standing collaboration with
co-Investigator Victor Nizet (UCSD). The results from our studies will provide essential guidance in designing
anti-virulence strategies, and may have applications in the development of a broadly neutralizing GAS vaccine.
A组链球菌(Gas,S。pyogenes)仍然是主要的公共卫生威胁。这个宽度的革兰氏
阳性细菌病原体会引起急性浸润性疾病,并引起严重的自身免疫性后遗症,
并负责全球范围内的发病率和死亡率。气体的基本病毒因素,
抗原可变的M蛋白质,使细菌能够通过免疫逃避op子杀虫剂
系统。 M蛋白通过募集特定的可溶性来承认吞噬细胞耐药性不可或缺的功能
人类蛋白质到阻塞主要opsonin c3b的沉积以及抗原的沉积的气表面
特定的Opsonic抗体 - 即C4b结合蛋白(C4BP),因子H(FH)和纤维蛋白原(FG)。
某些气体菌株,一种M样蛋白质可起到此功能。已知超过220 m的类型,而大多数M
蛋白质类型结合C4BP,FH或FG或这些组合,没有共识结合基序是M和
这些人类蛋白质中的任何一种,除了最近,由于我们的突破,最近C4BP的M样蛋白质。这
是因为募集这些抗偶然人蛋白的M蛋白的暴露部分是
序列变量。虽然抑制这些相互作用已显示出对免疫敏感的气体
杀人,缺乏共识约束的图案阻碍了针对这些目标的治疗目标
互动。我们最近在Buffalo等人的突破提供了解决此问题的解决方案。实际上,我们
发现隐藏在许多M蛋白的变量区域内是一种三维(3D)模式
保守用于结合C4BP。 M蛋白中的这种3D C4BP结合模式被分散(或隐藏)
在可变氨基酸的海洋中,这使得3D模式几乎无法通过初级识别
单独的序列。但是,由于手头的结构知识是指导模板,3D模式变为
在许多M类型的主要序列中易于识别。我们假设这与C4BP一样
隐藏在M和M样蛋白的可变区域内是3D模式,可保守
结合FH和FG。我们建议通过通过
在M和M样蛋白中揭示潜在保守的FH和FG结合3D模式。我们还建议
完成了我们在Buffalo等人发现和出版的3D模式上完成我们在C4BP上的工作。仅解释
在C4BP结合中实现的一组M蛋白的一半。我们建议通过X射线执行此操作
晶体学。通过M蛋白的晶体学研究,我们有广泛的记录,以及
已经获得了与C4BP,FH和FG结合的M蛋白的初始共结晶。在每种情况下,我们都会接受
我们的结构研究提供的高度详细信息水平的优势来确定精度
通过我们与我们长期合作,这些相互作用对病毒的功能贡献
共同投资者Victor Nizet(UCSD)。我们研究的结果将为设计提供基本的指导
反病毒策略,可能在开发广泛中和气体疫苗方面有应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PARTHO GHOSH其他文献
PARTHO GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PARTHO GHOSH', 18)}}的其他基金
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10526403 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10305645 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10063877 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
9896180 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Diversity-Generation and Variable Protein Displays in Pathogens and Phage
病原体和噬菌体的多样性生成和可变蛋白质展示
- 批准号:
8788249 - 财政年份:2012
- 资助金额:
$ 61.75万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
HMGB1-mediated host response to chronic bacterial infection
HMGB1介导的宿主对慢性细菌感染的反应
- 批准号:
10671706 - 财政年份:2020
- 资助金额:
$ 61.75万 - 项目类别:
HMGB1-mediated host response to chronic bacterial infection
HMGB1介导的宿主对慢性细菌感染的反应
- 批准号:
10267696 - 财政年份:2020
- 资助金额:
$ 61.75万 - 项目类别: